2,644
Views
0
CrossRef citations to date
0
Altmetric
Gastroenterology

Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease

, , ORCID Icon, , &
Pages 603-613 | Received 06 Mar 2023, Accepted 06 Apr 2023, Published online: 02 May 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.